Markets:

Overview

News

Currencies

International

Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

3.920 +0.240 (+6.52%)

Streaming Delayed Price Updated: 3:35 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 20, 2025

Via Benzinga

An Overview of Anavex Life Sciences's Earnings ↗

May 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 28, 2025

Via Benzinga

Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years ↗

April 07, 2025

Anavex's blarcamesine shows sustained cognitive and functional benefit in early Alzheimer's patients after four years of continuous treatment.

Via Benzinga

Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday? ↗

February 12, 2025

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New...

Via Benzinga

Topics Economy

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

Honda Motor, Rumble, Despegar.com And Other Big Stocks Moving Higher On Monday ↗

December 23, 2024

Via Benzinga

US Stocks To Open Higher As Wall Street Expects 'Santa Rally' In Shortened Trading Week: MicroStrategy, Palantir, Qualcomm Among Stocks In Focus ↗

December 23, 2024

U.S. stock futures advanced on Monday as two out of the four major index futures were trading higher in premarket trade.

Via Benzinga

Dow Jumps Around 500 Points But Records 3rd Straight Weekly Loss: Greed Index Moves To 'Fear' Zone ↗

December 23, 2024

Via Benzinga

Topics Stocks

Qualcomm, Limoneira And 3 Stocks To Watch Heading Into Monday ↗

December 23, 2024

Via Benzinga

Earnings Scheduled For December 23, 2024 ↗

December 23, 2024

Via Benzinga

Earnings Scheduled For February 12, 2025 ↗

February 12, 2025

Via Benzinga

Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz ↗

January 14, 2025

The intense retail focus on Anavex reflects a broader market interest in neurodegenerative therapies, especially following disappointing trial results from Cassava Sciences’ simufilam.

Via Stocktwits

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 26, 2024

Via Benzinga

Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday ↗

December 26, 2024

Via Benzinga

Short-Squeeze Target Anavex Life Sciences Gains Traction

December 26, 2024

Anavex Life Sciences stock market is set up for a short squeeze that could begin in early 2025 and increase the price by 400% or more.

Via MarketBeat

Greenfire Resources, Hut 8, TeraWulf, MicroStrategy And Other Big Stocks Moving Higher On Tuesday ↗

December 24, 2024

Via Benzinga

Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla? ↗

November 08, 2024

GameStop, SoFi, Tesla, Cassava Sciences and Anavex Life Sciences are the top five trending stocks on Stocktwits Friday. Here's a look at what's going on:

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 31, 2024

Via Benzinga

AVXL Stock Earnings: Anavex Life Sciences Misses EPS for Q3 2024 ↗

August 06, 2024

AVXL stock results show that Anavex Life Sciences missed analyst estimates for earnings per share the third quarter of 2024.

Via InvestorPlace

Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 29, 2024

Via Benzinga

Neurodegenerative Disease-Focused Anavex Life Sciences' Alzheimer's Candidate Slows Disease Progression By Almost 39% ↗

July 29, 2024

Anavex Life Sciences presented Phase 2b/3 study results at AAIC 2024, showing daily oral blarcamesine (ANAVEX2-73) significantly slows clinical decline in early Alzheimer's disease. The 48-week study...

Via Benzinga

Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket ↗

July 29, 2024

Via Benzinga

CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 16, 2024

Via Benzinga

Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

July 16, 2024

Via Benzinga

GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

June 03, 2024

Via Benzinga

AVXL ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

May 14, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses to Contact the Firm

May 13, 2024

From Schall Law

Via GlobeNewswire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Anavex Life Sciences Corp. (AVXL)

May 10, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

AVXL Stockholders: Additional Lawsuit Filed Against Anavex Life Sciences Corporation; Contact Robbins LLP Regarding the May 13, 2024 Lead Plaintiff Deadline

May 09, 2024

From Robbins LLP

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.